00
hrs
:
00
min
:
00
sec
for delivery on
★
Free over £60
If you cancel, all changes will be lost and the original order will remain unchanged.
29 July 2026
An INR blood test measures how quickly your blood clots, and it's one of the most common tests carried out in UK general practice, mostly because so many people take warfarin, an anticoagulant that slows down clotting to help prevent strokes and clots.
If you've just started warfarin, or your GP has recommended monitoring warfarin as part of your daily routine, this page covers what INR means, what a normal result looks like, why the test matters so much for people taking warfarin, and what changes if you test at home instead of a clinic.
INR stands for International Normalised Ratio, the figure your GP or anticoagulation clinic checks to confirm your blood is clotting at the level it should be. It's used worldwide because it standardises results: a reading from a lab in London means the same thing as a reading from a lab in Sydney. That wasn't always the case.
Laboratories used to report a raw number called prothrombin time, or PT, the number of seconds a blood sample took to clot. Labs used different reagents to run the test, so results could vary from one lab to the next. The international reference standard that created the INR system gave every laboratory one shared point of comparison, so a result reads the same everywhere.
You'll still sometimes see the test written as PT/INR, since INR is calculated directly from PT. Some people call it a blood thinning test, or simply a clotting test, since that's what it checks. In practice, your result will almost always come back to you as INR rather than PT.
If you're not taking an anticoagulant, your normal INR reference range sits roughly between 0.8 and 1.2, reflecting how quickly your blood clots without any medicine slowing it down. Once you start warfarin, the aim is to purposely move away from that range to a point where clotting takes two to three times longer than usual.
For most people on warfarin, that means a standard target of 2.0 to 3.0, a range built to let your team adjust your dose without constant fine-tuning.
Some conditions call for a higher target. A mechanical heart valve, for example, often needs a target closer to 2.5 to 3.5, sometimes higher depending on the valve's type and position, since the valve material gives clots more opportunity to form. Your own target is set by your anticoagulation team based on your diagnosis, so don't be surprised if it sits a little differently from the figures below.
Here's how the common targets compare:
| Who It's For | Target INR Range | Why This Range Is Used |
|---|---|---|
| Not on an anticoagulant | 0.8 to 1.2 | Reflects normal clotting speed with no medicine involved |
| Atrial fibrillation, DVT, or pulmonary embolism | 2.0 to 3.0 | The standard target for most people taking warfarin |
| Mechanical heart valve | 2.5 to 3.5 | Extra protection since clots can form on the valve material |
| Recurrent clot while on warfarin | 3.0 to 4.0 | Used when a target of 2.0 to 3.0 hasn't prevented a further clot |
These are general figures. Your anticoagulation team sets the target that fits your own diagnosis, and that's the number to remember.
An INR below your target range means your blood is clotting faster than it should, which raises your risk of a clot forming. An INR above your target range means the opposite: clotting is slower than it should be, which raises your risk of bleeding. Neither reading is something to manage on your own.
If a result comes back outside your range, your anticoagulation team will decide whether to adjust your dose, bring your next test forward, or simply hold your current dose and monitor.
Most day-to-day changes are minor. But some symptoms need attention no matter what your reading showed, and it helps to know them now rather than search for them in a hurry.
NHS guidance on warfarin lists the signs of serious bleeding to watch for:
If you notice any of these, contact your anticoagulation clinic, GP, or NHS 111 the same day. Call 999 if the bleeding is severe, or if you have any of the symptoms above affecting your speech or movement.
Most people end up testing their INR for one of three reasons: atrial fibrillation, a clot such as a DVT or a pulmonary embolism, or a mechanical heart valve. Each carries its own clotting risk, and warfarin plays a slightly different role depending on which one applies to you.
Whatever the reason, once warfarin starts, so does the testing. For most people it settles into a normal part of life rather than something they think about day to day.
Warfarin is an anticoagulant medicine, sometimes called a blood thinner, though it doesn't actually thin your blood. It works by reducing how much vitamin K your liver uses to build clotting factors, so clots take longer to form. Because the effect depends on vitamin K, several ordinary things can shift your INR between tests, which is why it’s important to keep monitoring even once your dose feels settled.
This page doesn't go into warfarin dosing or specific interactions, since that's something to work through directly with your anticoagulation team or pharmacist. What matters here is the principle: warfarin's effect can move around in response to daily life, and INR testing is how you and your team keep track of it.
Traditionally, INR monitoring happens at a hospital clinic or GP surgery, with a blood sample taken from a vein and sent off for testing. Home INR testing, also called self-testing or self-monitoring, lets you check your own level using a small meter and a finger prick sample, without needing to visit a clinic every time.
NICE's guidance on point-of-care self-monitoring recommends this approach for adults and children with atrial fibrillation or heart valve disease on long-term warfarin, provided the person prefers this way of testing and is able, physically and mentally, to carry it out consistently, with a carer trained to help if needed. Many anticoagulation clinics now support patients who choose this route, and the same guidance expects the equipment to be checked regularly against a clinic meter to confirm it stays accurate.
Once you're set up, the process itself is short:
In the United States, this same test is often sold as a protime test or protime check, since PT and INR are reported together on the one reading. Whatever it's called, home testing doesn't remove your clinic from the picture entirely. It just changes how often you need to visit them.
A few quick answers to the questions that come up most.
No. A PT/INR test doesn't need fasting or any special preparation, so you can eat and drink as usual beforehand, unless your clinic has told you otherwise for a separate reason.
It varies by stage of treatment. NHS guidance on warfarin blood tests explains that testing is usually daily or every few days when you first start, moving to roughly every twelve weeks once your dose has settled into your target range, though some people need to test more often depending on how stable their reading stays.
Yes, and it happens often. Diet, medicines, alcohol, or illness can all shift your INR between tests without any change to your dose, which is why testing continues even once you feel settled on your current dose.
Used correctly, yes. NICE's quality assurance requirements for home INR meters call for regular checks against a clinic coagulometer, and most clinics build this comparison into your self-testing setup, so any drift between your meter and the lab gets caught early.
There's no charge for the blood test itself when it's arranged through your GP or anticoagulation clinic as part of NHS care. If you choose home testing, you buy the meter, test strips, and lancets yourself, a cost the NHS doesn't cover automatically.
If you don't yet have a diagnosis or a warfarin prescription, an INR test starts with your GP, who can arrange the blood test and explain what your result means for you.
If you're already taking warfarin, your anticoagulation clinic or GP practice will already have a monitoring schedule in place, whether that's a clinic appointment or a home testing arrangement you've set up together.
If home testing is something you and your clinical team have discussed and agreed on, moving to a connected meter can mean fewer trips to the clinic and a clearer picture of your own trend over time, since many home meters flag results that drift outside your target as soon as they happen.
At ESM, we stock the Roche CoaguChek INRange, the current meter in the same CoaguChek family named in NICE's guidance on home testing, along with its test strips and lancets, so everything you need arrives in one place.
Shop the CoaguChek INRange